Genmab — April 2014
-
det er lidt besynderligt - US rebounder meget fint og ligger 2% oppe. Uden at det på nogen måder har effekt på GEN.
-
det var også det jeg tænkte - men vi kan jo nok ikke vide det med sikkerhed
-
US nærmest krakker da lige nu her
-
J&J har aflagt Q1 og Ibrutinib salgsdata er ikke engang nævnt så tror heller ikke de er fantastiske
http://www.investor.jnj.com/releasedetail.cfm?ReleaseID=840212 -
nedt
uren bliver enten stoppet eller forstærket af den beslutning FDA kommer med her en af de kommende dage
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind